Detailansicht

Wissensnetz

Person

Andreas Stallmach (1960-)

Internist

Name	Andreas Stallmach
Zeit	1960- (Lebensdaten)
Ort	Jena (Wirkungsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Internist (charakteristischer Beruf)
Variante	A. Stallmach
Beziehung	Universitätsklinikum Jena Klinik für Innere Medizin IV (Jena) Friedrich-Schiller-Universität Jena. Medizinische Fakultät Integriertes Forschungs- und Behandlungszentrum Sepsis und Sepsisfolgen
Weitere Angaben	Dissertation, Universität Hamburg, 1985
Datensatztyp	Person
GND-Nummer	1116442140
Datensatz-ID	1116442140
Beteiligt an alle anzeigen Pathophysiology of IBD as a Key Strategy for Polymeric Nanoparticle Development Induction and maintenance of mucosal healing in Crohn’s disease with ustekinumab in clinical practice across all care levels in Germany (MUCUS) Anti‐Inflammatory Potential of Beclometasone‐Loaded Filomicelles on Activated Human Monocytes Post-COVID-Patienten mit persistierenden chemosensorischen Symptomen sind in der Bevölkerung selten Correction to: Clinical and surgical factors for successful stoma reversal in patients with Crohn’s disease—results of a retrospective cohort study Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline : März 2024 – AWMF-Registernummer: 021-004 Leitlinienreport der aktualisierten S2k-Leitlinie Gastrointestinale Infektionen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) : Version 2.0 – November 2023 – AWMF-Registernummer: 021–024 S2k-Leitlinie Gastrointestinale Infektionen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) : Version 2.0 – November 2023 – AWMF-Registernummer: 021–024 Verbesserungsbedarf in der Versorgung von Patienten/-innen mit Clostridioides-difficile-lnfektionen (CDI) – Experten/-innenmeinung im internationalen Vergleich Update des Addendums zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch-entzündlichen Darmerkrankungen in Bezug auf COVID-19 (Version 2.0) : Dezember 2023 – AWMF-Register-Nr. 021-009, 021-004 Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles (Small 21/2024) Schwangerschaft und Stillen mit chronisch-entzündlichen Darmerkrankungen The gastrointestinal microbiota in the development of ME/CFS : a critical view and potential perspectives Fatal pulmonary hemorrhage, pneumothorax and skin necrosis caused by IRIS to an Aspergillus flavus infection in a young patient with metamizole associated agranulocytosis Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months Feasibility studies of multimodal nonlinear endoscopy using multicore fiber bundles for remote scanning from tissue sections to bulk organs Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study A hypoarousal model of neurological post-COVID syndrome: the relation between mental fatigue, the level of central nervous activation and cognitive processing speed Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography Fäkaler Mikrobiota-Transfer (FMT) in Deutschland – Status und Perspektive Trends in the epidemiology of Clostridioides difficile infection in Germany Ambulante Long/Post-COVID-Versorgung: Analyse möglicher Barrieren und Wünsche von Betroffenen an die ärztliche Betreuung Introduction of mandatory masking in health care and community: experience from Jena, Germany Folgen nach SARS-CoV-2-Infektion einschließlich Post-COVID-Syndrom Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university hospital: follow-up of the prospective Co-HCW seroprevalence study Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis Detection of duodenal villous atrophy on endoscopic images using a deep learning algorithm Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy : a retrospective, observational study Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease Intestinal epithelial barrier integrity investigated by label-free techniques in ulcerative colitis patients Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial Meta-Analyse zu Aspirin als Therapie-Ergänzung beim kolorektalen Karzinom Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation Mobile primary healthcare for post-COVID patients in rural areas : a proof-of-concept study Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID Retrospektive Überprüfung verschiedener diagnostischer Algorithmen zur Diagnostik einer CMV-Infektion bei Patienten mit chronisch-entzündlichen Darmerkrankungen Rezidivrate bei Patienten mit Morbus Crohn nach medikamentöser Behandlung mit Biologika oder chirurgischem Eingriff : eine Metaanalyse Spektrum und Ausprägung der Langzeitsymptomatik bei Patientinnen und Patienten mit Post-COVID Unerwünschte Ereignisse beim fäkalen Mikrobiomtransfer bei Patienten mit chronisch-entzündlichen Darmerkrankungen Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography Correction to: Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis Antibiotika-assoziierte Diarrhoe Clinical and surgical factors for successful stoma reversal in patients with Crohn’s disease—results of a retrospective cohort study Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis Graft function and health status in renal transplant recipients hospitalized for COVID-19: a single center case series Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical study Fäkaler Mikrobiomtransfer – Indikationen, Risiken und Chancen Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis Bakterielle hepatobiliäre Infektionen : Erregerspektrum, antimikrobielle Resistenzentwicklung und aktuelle Therapiekonzepte Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial Meta-analysis of aspirin-guided therapy of colorectal cancer

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Andreas Stallmach (1960-)

Pathophysiology of IBD as a Key Strategy for Polymeric Nanoparticle Development

Induction and maintenance of mucosal healing in Crohn’s disease with ustekinumab in clinical practice across all care levels in Germany (MUCUS)

Anti‐Inflammatory Potential of Beclometasone‐Loaded Filomicelles on Activated Human Monocytes

Post-COVID-Patienten mit persistierenden chemosensorischen Symptomen sind in der Bevölkerung selten

Correction to: Clinical and surgical factors for successful stoma reversal in patients with Crohn’s disease—results of a retrospective cohort study

Taking IBD Treatment in STRIDE: How Objective Disease Assessment Is Essential for the Successful Implementation of Treat-to-Target Strategies

Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline : März 2024 – AWMF-Registernummer: 021-004

Leitlinienreport der aktualisierten S2k-Leitlinie Gastrointestinale Infektionen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) : Version 2.0 – November 2023 – AWMF-Registernummer: 021–024

S2k-Leitlinie Gastrointestinale Infektionen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) : Version 2.0 – November 2023 – AWMF-Registernummer: 021–024

Verbesserungsbedarf in der Versorgung von Patienten/-innen mit Clostridioides-difficile-lnfektionen (CDI) – Experten/-innenmeinung im internationalen Vergleich

Update des Addendums zu den S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Betreuung von Patienten mit chronisch-entzündlichen Darmerkrankungen in Bezug auf COVID-19 (Version 2.0) : Dezember 2023 – AWMF-Register-Nr. 021-009, 021-004

Microbiota-Based Therapeutics as New Standard-of-Care Treatment for Recurrent Clostridioides difficile Infection

Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles (Small 21/2024)

Schwangerschaft und Stillen mit chronisch-entzündlichen Darmerkrankungen

The gastrointestinal microbiota in the development of ME/CFS : a critical view and potential perspectives

Fatal pulmonary hemorrhage, pneumothorax and skin necrosis caused by IRIS to an Aspergillus flavus infection in a young patient with metamizole associated agranulocytosis

Selective Uptake Into Inflamed Human Intestinal Tissue and Immune Cell Targeting by Wormlike Polymer Micelles

Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months

Feasibility studies of multimodal nonlinear endoscopy using multicore fiber bundles for remote scanning from tissue sections to bulk organs

Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study

A hypoarousal model of neurological post-COVID syndrome: the relation between mental fatigue, the level of central nervous activation and cognitive processing speed

Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography

Fäkaler Mikrobiota-Transfer (FMT) in Deutschland – Status und Perspektive

Trends in the epidemiology of Clostridioides difficile infection in Germany

Ambulante Long/Post-COVID-Versorgung: Analyse möglicher Barrieren und Wünsche von Betroffenen an die ärztliche Betreuung

Introduction of mandatory masking in health care and community: experience from Jena, Germany

Folgen nach SARS-CoV-2-Infektion einschließlich Post-COVID-Syndrom

Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease

Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university hospital: follow-up of the prospective Co-HCW seroprevalence study

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis

A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis

Detection of duodenal villous atrophy on endoscopic images using a deep learning algorithm

Early ribavirin for hepatitis E virus infection in patients receiving immunosuppressive therapy : a retrospective, observational study

Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease

Intestinal epithelial barrier integrity investigated by label-free techniques in ulcerative colitis patients

Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial

Meta-Analyse zu Aspirin als Therapie-Ergänzung beim kolorektalen Karzinom

Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation

Mobile primary healthcare for post-COVID patients in rural areas : a proof-of-concept study

Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID

Retrospektive Überprüfung verschiedener diagnostischer Algorithmen zur Diagnostik einer CMV-Infektion bei Patienten mit chronisch-entzündlichen Darmerkrankungen

Rezidivrate bei Patienten mit Morbus Crohn nach medikamentöser Behandlung mit Biologika oder chirurgischem Eingriff : eine Metaanalyse

Spektrum und Ausprägung der Langzeitsymptomatik bei Patientinnen und Patienten mit Post-COVID

Unerwünschte Ereignisse beim fäkalen Mikrobiomtransfer bei Patienten mit chronisch-entzündlichen Darmerkrankungen

Visualizing exertional dyspnea in a post-COVID patient using electrical impedance tomography

Correction to: Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis

Antibiotika-assoziierte Diarrhoe

Clinical and surgical factors for successful stoma reversal in patients with Crohn’s disease—results of a retrospective cohort study

Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis

Graft function and health status in renal transplant recipients hospitalized for COVID-19: a single center case series

Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical study

Fäkaler Mikrobiomtransfer – Indikationen, Risiken und Chancen

Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis

Post-COVID-19 condition is not only a question of persistent symptoms: structured screening including health-related quality of life reveals two separate clusters of post-COVID

Mobile primary healthcare for post-COVID patients in rural areas: a proof-of-concept study

Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis

Bakterielle hepatobiliäre Infektionen : Erregerspektrum, antimikrobielle Resistenzentwicklung und aktuelle Therapiekonzepte

Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial

Meta-analysis of aspirin-guided therapy of colorectal cancer